326030.KS
SK Biopharmaceuticals Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 86,400.00
+0.12%Leverage
- Debt / equity
- 0.05x
- Net debt / equity
- -0.32x
- Debt / assets
- 0.03x
- Debt / EBITDA
- 0.21x
- Net debt / EBITDA
- -1.40x
Liquidity & coverage
- Current ratio
- 2.72x
- Quick ratio
- 2.42x
- Cash ratio
- 1.18x
- Interest coverage
- 54.31x
- EBITDA / interest
- 42.27x
- Working capital
- KRW 554.9B
Cash & dividend
- FCF / debt
- 4.99x
- Cash flow / debt
- 5.15x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026